Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer
Status:
Withdrawn
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This study is randomized phase III trial designed to assess whether (preoperative)
neoadjuvant chemotherapy followed by surgery plus adjuvant chemotherapy with gemcitabine and
cisplatin (experimental treatment) improves 3-year disease-free survival, compared to surgery
plus adjuvant chemotherapy with gemcitabine and cisplatin (standard treatment) in stage IB,
IIA, IIB and T3N1 non-small cell lung cancer